DMH4, a VEGFR2 inhibitor, effectively suppresses growth and invasion of lung cancer cells-Reference-Cited by-同舟云学术

DMH4, a VEGFR2 inhibitor, effectively suppresses growth and invasion of lung cancer cells

Published:2018-02-01 Issue:1 Volume:16 Page:46-50
ISSN:1214-021X
Container-title:Journal of Applied Biomedicine
language:
Short-container-title:JAB

Author:

Li Hao,Ha Helen L.,Ding Xiaoxu,Bae Chay,Gazy Nicky,Hao Jijun,Zhong Li

Funder

National Natural Science Foundation of China

Western University of Health Sciences

Publisher

University of South Bohemia in Ceske Budejovice

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

http://jab.zsf.jcu.cz/doi/10.1016/j.jab.2017.10.006.pdf

Reference21 articles.

1. Mechanisms of angiogenesis and arteriogenesis

2. FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer

3. Cancer treatment and survivorship statistics, 2014

4. Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain endothelial cells acquire blood-brain barrier properties in the absence of Vegf-dependent CNS angiogenesis;Developmental Biology;2023-02

2. An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry;Biomedicine & Pharmacotherapy;2022-02

3. Synthesis of Piperidine Conjugated Dihydroquinazolin-4(1H)-ones and their Antiproliferative Activity, Molecular Docking Studies and DFT Calculations;Letters in Drug Design & Discovery;2019-12-31